REPL Stock Analysis: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$8.14
0.53 (6.96%)
▲
5d:
+7.96%
30d:
+12.28%
90d:
-16.26%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
REPL is down 5.2% this week, but smart money is accumulating calls. Top strike: $10 2026-05-15 with 767 OI. Call ratio: 100% View Scanner →
Strength: 7.6/10
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: REPL shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: REPL shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $8.14, which is considered slightly high relative to its 30-day fair value range of $7.02 to $8.02.
Technical Outlook: Technically, REPL is in a strong downtrend. The price is approaching resistance at $8.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: REPL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.86 (+69.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, REPL is in a strong downtrend. The price is approaching resistance at $8.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 7.0% recently.
Market Sentiment: REPL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.86 (+69.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$7.02 -
$8.02
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.0%)
- BULLISH: Trading 69.0% below Wall St target ($12.86)
Fair Price Analysis
30-Day Fair Range
$7.02 -
$8.02
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$6.71
Resistance Level
$8.22
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.79
Wall Street Target
$12.86
(+69.0%)
Share & Embed Analysis
Last updated: April 02, 2026 12:25 PM ET
Data refreshes hourly during market hours. Next update: 1:25 PM
Data refreshes hourly during market hours. Next update: 1:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Kapil Dhingra
SELL
3169 shares
2025-12-09
Sushil Patel
SELL
10000 shares
2025-12-02
Christopher Sarchi
SELL
5208 shares
2025-11-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1018 | 55 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$547 | 52 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
